Name | Number of supported studies | Average coverage | |
---|---|---|---|
non-classical monocyte | 6 studies | 28% ± 13% | |
epithelial cell | 3 studies | 39% ± 15% |
Insufficient scRNA-seq data for expression of PLAGL2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1982.24 | 1445 / 1445 | 100% | 58.65 | 183 / 183 |
stomach | 100% | 1557.26 | 359 / 359 | 100% | 64.69 | 286 / 286 |
ovary | 100% | 2005.47 | 180 / 180 | 100% | 57.19 | 429 / 430 |
intestine | 100% | 1668.17 | 966 / 966 | 99% | 54.70 | 524 / 527 |
lung | 100% | 1773.71 | 576 / 578 | 98% | 36.64 | 1135 / 1155 |
prostate | 100% | 1448.75 | 245 / 245 | 98% | 16.61 | 490 / 502 |
uterus | 100% | 1527.75 | 170 / 170 | 98% | 31.54 | 448 / 459 |
bladder | 100% | 1109.00 | 21 / 21 | 97% | 31.07 | 490 / 504 |
breast | 100% | 899.28 | 459 / 459 | 97% | 21.08 | 1083 / 1118 |
skin | 100% | 1826.91 | 1809 / 1809 | 96% | 19.40 | 452 / 472 |
pancreas | 99% | 847.31 | 324 / 328 | 95% | 16.09 | 169 / 178 |
thymus | 100% | 1383.99 | 653 / 653 | 93% | 15.04 | 562 / 605 |
brain | 97% | 716.27 | 2561 / 2642 | 96% | 13.88 | 674 / 705 |
kidney | 100% | 1201.36 | 89 / 89 | 80% | 11.52 | 718 / 901 |
adrenal gland | 100% | 856.81 | 258 / 258 | 69% | 7.81 | 159 / 230 |
liver | 100% | 617.44 | 225 / 226 | 35% | 4.41 | 142 / 406 |
lymph node | 0% | 0 | 0 / 0 | 100% | 25.44 | 29 / 29 |
spleen | 100% | 1742.11 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 36.39 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 8.24 | 1 / 1 |
adipose | 100% | 917.16 | 1198 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 1723.47 | 900 / 929 | 0% | 0 | 0 / 0 |
heart | 97% | 763.03 | 832 / 861 | 0% | 0 | 0 / 0 |
muscle | 94% | 599.33 | 751 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 90% | 565.18 | 1203 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 80% | 8.22 | 64 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_2001244 | Biological process | positive regulation of intrinsic apoptotic signaling pathway |
GO_0034378 | Biological process | chylomicron assembly |
GO_0006629 | Biological process | lipid metabolic process |
GO_0009791 | Biological process | post-embryonic development |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0005634 | Cellular component | nucleus |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0005515 | Molecular function | protein binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0043565 | Molecular function | sequence-specific DNA binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | PLAGL2 |
Protein name | Zinc finger protein PLAGL2 (Pleiomorphic adenoma-like protein 2) |
Synonyms | KIAA0198 |
Description | FUNCTION: Shows weak transcriptional activatory activity. |
Accessions | Q9UPG8 ENST00000246229.5 |